famotidine

Generic: famotidine

Labeler: bluepoint laboratories
NDC Directory HUMAN OTC DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name famotidine
Generic Name famotidine
Labeler bluepoint laboratories
Dosage Form TABLET
Routes
ORAL
Active Ingredients

famotidine 10 mg/1

Manufacturer
BluePoint Laboratories

Identifiers & Regulatory

Product NDC 68001-494
Product ID 68001-494_f79353ac-03fd-35b1-e053-6394a90a86ae
Product Type HUMAN OTC DRUG
Marketing Category ANDA
Application Number ANDA206531
Listing Expiration 2026-12-31
Marketing Start 2021-04-07

Pharmacologic Class

Established (EPC)
histamine-2 receptor antagonist [epc]
Mechanism of Action
histamine h2 receptor antagonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 68001494
Hyphenated Format 68001-494

Supplemental Identifiers

RxCUI
199047
UPC
0368001494045
UNII
5QZO15J2Z8
NUI
N0000000151 N0000175784

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name famotidine (source: ndc)
Generic Name famotidine (source: ndc)
Application Number ANDA206531 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 10 mg/1
source: ndc
Packaging
  • 1 BOTTLE in 1 CARTON (68001-494-04) / 30 TABLET in 1 BOTTLE
  • 1 BOTTLE in 1 CARTON (68001-494-06) / 60 TABLET in 1 BOTTLE
source: ndc

Packages (2)

Ingredients (1)

famotidine (10 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "f79353ac-03fd-35b1-e053-6394a90a86ae", "openfda": {"nui": ["N0000000151", "N0000175784"], "upc": ["0368001494045"], "unii": ["5QZO15J2Z8"], "rxcui": ["199047"], "spl_set_id": ["befd8d44-c6f7-eca2-e053-2995a90a714b"], "pharm_class_epc": ["Histamine-2 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Histamine H2 Receptor Antagonists [MoA]"], "manufacturer_name": ["BluePoint Laboratories"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (68001-494-04)  / 30 TABLET in 1 BOTTLE", "package_ndc": "68001-494-04", "marketing_start_date": "20210407"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (68001-494-06)  / 60 TABLET in 1 BOTTLE", "package_ndc": "68001-494-06", "marketing_start_date": "20210617"}], "brand_name": "Famotidine", "product_id": "68001-494_f79353ac-03fd-35b1-e053-6394a90a86ae", "dosage_form": "TABLET", "pharm_class": ["Histamine H2 Receptor Antagonists [MoA]", "Histamine-2 Receptor Antagonist [EPC]"], "product_ndc": "68001-494", "generic_name": "Famotidine", "labeler_name": "BluePoint Laboratories", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Famotidine", "active_ingredients": [{"name": "FAMOTIDINE", "strength": "10 mg/1"}], "application_number": "ANDA206531", "marketing_category": "ANDA", "marketing_start_date": "20210407", "listing_expiration_date": "20261231"}